Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment

Q Yang, M Ciebiera, MV Bariani, M Ali… - Endocrine …, 2022 - academic.oup.com
Uterine fibroids are benign monoclonal neoplasms of the myometrium, representing the
most common tumors in women worldwide. To date, no long-term or noninvasive treatment …

Inhibitors of cyclin-dependent kinases as cancer therapeutics

SR Whittaker, A Mallinger, P Workman… - Pharmacology & …, 2017 - Elsevier
Over the past two decades there has been a great deal of interest in the development of
inhibitors of the cyclin-dependent kinases (CDKs). This attention initially stemmed from …

A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states

NM Dräger, SM Sattler, CTL Huang, OM Teter… - Nature …, 2022 - nature.com
Microglia are emerging as key drivers of neurological diseases. However, we lack a
systematic understanding of the underlying mechanisms. Here, we present a screening …

Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors

M Peyressatre, C Prével, M Pellerano, MC Morris - Cancers, 2015 - mdpi.com
Cyclin-dependent kinases (CDK/Cyclins) form a family of heterodimeric kinases that play
central roles in regulation of cell cycle progression, transcription and other major biological …

The Mediator complex and transcription regulation

ZC Poss, CC Ebmeier, DJ Taatjes - Critical reviews in biochemistry …, 2013 - Taylor & Francis
The Mediator complex is a multi-subunit assembly that appears to be required for regulating
expression of most RNA polymerase II (pol II) transcripts, which include protein-coding and …

Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs

R Roskoski Jr - Pharmacological research, 2016 - Elsevier
Cyclins and cyclin-dependent protein kinases (CDKs) are important regulatory components
that are required for cell cycle progression. The levels of the cell cycle CDKs are generally …

HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia

MD Galbraith, MA Allen, CL Bensard, X Wang… - Cell, 2013 - cell.com
The transcription factor HIF1A is a key mediator of the cellular response to hypoxia. Despite
the importance of HIF1A in homeostasis and various pathologies, little is known about how it …

The mediator complex: at the nexus of RNA polymerase II transcription

C Jeronimo, F Robert - Trends in Cell Biology, 2017 - cell.com
Mediator is an essential, large, multisubunit, transcriptional co-activator highly conserved
across eukaryotes. Mediator interacts with gene-specific transcription factors at enhancers …

CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer

ML McCleland, K Mesh, E Lorenzana… - The Journal of …, 2016 - Am Soc Clin Investig
Colon tumors arise in a stepwise fashion from either discrete genetic perturbations or
epigenetic dysregulation. To uncover the key epigenetic regulators that drive colon cancer …

The Mediator kinase module: an interface between cell signaling and transcription

O Luyties, DJ Taatjes - Trends in biochemical sciences, 2022 - cell.com
The Mediator complex controls RNA polymerase II (pol II) activity by coordinating the
assembly of pol II regulatory factors at transcription start sites and by mediating interactions …